These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9231215)

  • 1. Human infection with Onchocerca volvulus does not affect the T helper cell phenotype of the cellular immune response to mycobacterial antigen.
    Cooper PJ; Guderian RH; Nutman TB; Taylor DW
    Trans R Soc Trop Med Hyg; 1997; 91(3):350-2. PubMed ID: 9231215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1.
    Sentongo E; Rubaale T; Büttner DW; Brattig NW
    Parasite Immunol; 1998 Sep; 20(9):431-9. PubMed ID: 9767610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onchocerciasis modulates the immune response to mycobacterial antigens.
    Stewart GR; Boussinesq M; Coulson T; Elson L; Nutman T; Bradley JE
    Clin Exp Immunol; 1999 Sep; 117(3):517-23. PubMed ID: 10469056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
    Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
    J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density.
    Brattig NW; Lepping B; Timmann C; Büttner DW; Marfo Y; Hamelmann C; Horstmann RD
    J Infect Dis; 2002 Apr; 185(8):1148-54. PubMed ID: 11930325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.
    Cooper PJ; Mancero T; Espinel M; Sandoval C; Lovato R; Guderian RH; Nutman TB
    J Infect Dis; 2001 Jun; 183(11):1662-8. PubMed ID: 11343216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-type hypersensitivity reactions to Onchocerca volvulus antigens in exposed and non-exposed African individuals.
    Burchard GD; Brattig NW; Kruppa TF; Horstmann RD
    Trans R Soc Trop Med Hyg; 1999; 93(1):103-5. PubMed ID: 10492804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
    Timmann C; Abraha RS; Hamelmann C; Buttner DW; Lepping B; Marfo Y; Brattig N; Horstmann RD
    Br J Dermatol; 2003 Oct; 149(4):782-7. PubMed ID: 14616370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.
    Doetze A; Satoguina J; Burchard G; Rau T; Löliger C; Fleischer B; Hoerauf A
    Int Immunol; 2000 May; 12(5):623-30. PubMed ID: 10784608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10.
    Cooper PJ; Espinel I; Paredes W; Guderian RH; Nutman TB
    J Infect Dis; 1998 Oct; 178(4):1133-8. PubMed ID: 9806045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
    Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
    Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.
    Ward DJ; Nutman TB; Zea-Flores G; Portocarrero C; Lujan A; Ottesen EA
    J Infect Dis; 1988 Mar; 157(3):536-43. PubMed ID: 3125261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.